Roselabs
Tapetide Score
Data-driven rating, 0–100. How it works →
No Tapetide Score has been computed for this stock yet.
Key Insights
Strengths
1- Stock is trading at 0.64 times its book value
Weaknesses
3- Company has low interest coverage ratio.
- Company has a low return on equity of -1.23% over last 3 years.
- Company has high debtors of 181 days.
Technical Indicators
Oscillators
Bullish
Overall
Bearish
Moving Averages
Bearish
Growth Rate
change over 1 year
change over 1 year
Quarterly Results
| Particulars | Mar 2013 | Jun 2013 | Sep 2013 | Dec 2013 | Mar 2014 | Jun 2014 | Sep 2014 | Dec 2014 | Mar 2015 | Jun 2015 | Sep 2015 | Dec 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 27.98 | 28.13 | 15.87 | 18.57 | 24.77 | 12.1 | 17.06 | 3.85 | 4.13 | 0.55 | 0.41 | 0.57 |
| Expenses | 27.23 | 27.53 | 15.57 | 18.13 | 24.2 | 11.65 | 17 | 3.61 | 4.13 | 0.51 | 0.4 | 0.55 |
| Operating Profit | 0.75 | 0.6 | 0.3 | 0.44 | 0.57 | 0.45 | 0.06 | 0.24 | 0 | 0.04 | 0.01 | 0.02 |
| OPM % | 2.68% | 2.13% | 1.89% | 2.37% | 2.3% | 3.72% | 0.35% | 6.23% | 0% | 7.27% | 2.44% | 3.51% |
| Other Income | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0.43 | 0.37 | 0.36 | 0.37 | 0.7 | 0.47 | 0 | 0.31 | 0.33 | 0 | 0 | 0 |
| Depreciation | 0.03 | 0.04 | 0.03 | 0.03 | 0.03 | 0.03 | 0.04 | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 |
| PBT | 0.3 | 0.19 | -0.09 | 0.04 | -0.16 | -0.05 | 0.02 | -0.1 | -0.36 | 0.02 | -0.01 | 0 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
| Net Profit | 0.3 | 0.19 | -0.1 | 0.03 | -0.16 | -0.06 | 0.03 | -0.1 | -0.36 | 0.02 | -0.01 | 0 |
| EPS (₹) | 0.3 | 0.19 | -0.1 | 0.03 | -0.16 | -0.06 | 0.03 | -0.1 | -0.36 | 0.02 | -0.01 | 0 |
Profit & Loss
| Particulars | Mar 2007 | Mar 2008 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 1.11 | 0.93 | 50.2 | 71.62 | 88.59 | 33.11 | 5.66 |
| Expenses | 1.1 | 0.95 | 48.84 | 69.39 | 86.98 | 33.14 | 5.59 |
| Operating Profit | 0.01 | -0.02 | 1.36 | 2.23 | 1.61 | -0.03 | 0.07 |
| OPM % | 0.9% | -2.15% | 2.71% | 3.11% | 1.82% | -0.09% | 1.24% |
| Other Income | 0.01 | 0.03 | -0.02 | -0.04 | 0.03 | 0 | 0 |
| Interest | 0 | 0 | 1.07 | 1.47 | 1.54 | 0.52 | 0.33 |
| Depreciation | 0.01 | 0.01 | 0.1 | 0.13 | 0.15 | 0.24 | 0.09 |
| PBT | 0.01 | 0 | 0.17 | 0.59 | -0.05 | -0.79 | -0.35 |
| Tax % | 0% | — | 41.18% | 37.29% | 60% | -2.53% | — |
| Net Profit | 0.01 | 0 | 0.1 | 0.37 | -0.08 | -0.78 | -0.35 |
| EPS (₹) | 0.03 | 0 | 0.1 | 0.37 | -0.08 | -0.78 | -0.35 |
| Div. Payout % | 0% | — | 0% | 0% | 0% | 0% | — |
Balance Sheet
| Particulars | Mar 2007 | Mar 2008 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 |
|---|---|---|---|---|---|---|
| Equity Capital | 3 | 3 | 10 | 10 | 10 | 10 |
| Reserves | 0.06 | 0.06 | 0.18 | 2.8 | 2.73 | 1.95 |
| Borrowings | 0.02 | 0.01 | 13.59 | 8.65 | 11.53 | 10.76 |
| Other Liabilities | 0.09 | 1.55 | 6.82 | 5.6 | 33.88 | 11.05 |
| Total Liabilities | 3.17 | 4.62 | 30.59 | 27.05 | 58.14 | 33.76 |
| Fixed Assets | 0.06 | 0.05 | 0.87 | 1.01 | 1.81 | 1.02 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 1.98 | 2.66 | 7 | 1.73 | 6.88 | 6.88 |
| Other Assets | 1.13 | 1.91 | 22.72 | 24.31 | 49.45 | 25.86 |
| Total Assets | 3.17 | 4.62 | 30.59 | 27.05 | 58.14 | 33.76 |
Cash Flow
| Particulars | Mar 2007 | Mar 2008 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 |
|---|---|---|---|---|---|---|
| Operating | -0.43 | 0.67 | -1.17 | -0.53 | -1.16 | 0.05 |
| Investing | 0.47 | -0.68 | -7.18 | 4.98 | 5 | -0.35 |
| Financing | -0.01 | -0.01 | 8.49 | -3.95 | -4.01 | -1.33 |
| Net Cash Flow | 0.03 | -0.02 | 0.14 | 0.5 | -0.17 | -1.63 |
| Free Cash Flow | -0.43 | 0.67 | -1.36 | -0.84 | -1.46 | -0.3 |
| CFO/OP | -4,300 | -3,350 | -84 | -22 | -70 | -167 |
Ratios
| Particulars | Mar 2007 | Mar 2008 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 |
|---|---|---|---|---|---|---|
| Debtor Days | 191 | 235 | 135 | 105 | 151 | 181 |
| Inventory Days | 28.91 | 38.65 | 21.73 | 9.05 | 6.29 | 18.98 |
| Days Payable | 32.52 | 21.47 | 50.76 | 22.61 | 140 | 108 |
| Cash Conversion Cycle | 187 | 253 | 106 | 91.33 | 17.51 | 92.2 |
| Working Capital Days | 326 | 130 | 62.97 | 51.37 | 17.1 | 51.92 |
| ROCE % | — | 0% | — | 9.33% | 6.56% | -1.15% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Roselabs insights
54 extracted metrics + investor summaries across FY07–FY16.
Documents
Frequently Asked Questions about Roselabs
What does Roselabs Ltd do?
Which sector does Roselabs Ltd belong to?
Company Information
Roselabs entered the area of providing life saving drug's and a lot more pharmaceutical formulations with best quality.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/392280.md for Roselabs Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.